vs

Brookdale Senior Living Inc.(BKD)与Bio-Techne(TECH)财务数据对比。点击上方公司名可切换其他公司

Brookdale Senior Living Inc.的季度营收约是Bio-Techne的2.5倍($754.1M vs $295.9M)。Bio-Techne净利率更高(12.8% vs -5.3%,领先18.1%)。Brookdale Senior Living Inc.同比增速更快(-3.4% vs -6.4%)。过去两年Bio-Techne的营收复合增速更高(4.2% vs -1.9%)

布鲁克代尔老年生活公司成立于1978年,总部位于美国田纳西州布伦特伍德,是美国规模最大的老年住宅运营商,业务覆盖全美各地的养老社区,目前服务超过6万名入住老年人。

Bio-Techne是美国头部生命科学企业,面向科研、诊断及生物工艺市场需求,研发、生产并销售生命科学试剂、仪器及配套服务,产品及解决方案广泛应用于基础研究、体外诊断、生物医药研发生产等场景,可为相关领域从业者提供可靠的专业工具支持。

BKD vs TECH — 直观对比

营收规模更大
BKD
BKD
是对方的2.5倍
BKD
$754.1M
$295.9M
TECH
营收增速更快
BKD
BKD
高出3.0%
BKD
-3.4%
-6.4%
TECH
净利率更高
TECH
TECH
高出18.1%
TECH
12.8%
-5.3%
BKD
两年增速更快
TECH
TECH
近两年复合增速
TECH
4.2%
-1.9%
BKD

损益表 — Q4 2025 vs Q2 2026

指标
BKD
BKD
TECH
TECH
营收
$754.1M
$295.9M
净利润
$-40.0M
$38.0M
毛利率
24.9%
64.6%
营业利润率
3.0%
18.4%
净利率
-5.3%
12.8%
营收同比
-3.4%
-6.4%
净利润同比
52.4%
68.3%
每股收益(稀释后)
$-0.18
$0.24

绿色 = 该指标领先。财年不对齐时期间可能不同

8季度营收与利润趋势

并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配

营收
BKD
BKD
TECH
TECH
Q4 25
$754.1M
$295.9M
Q3 25
$813.2M
Q2 25
$812.9M
$317.0M
Q1 25
$813.9M
$316.2M
Q4 24
$780.9M
$297.0M
Q3 24
$784.2M
$289.5M
Q2 24
$777.5M
$306.1M
Q1 24
$782.8M
$303.4M
净利润
BKD
BKD
TECH
TECH
Q4 25
$-40.0M
$38.0M
Q3 25
$-114.7M
Q2 25
$-43.0M
$-17.7M
Q1 25
$-65.0M
$22.6M
Q4 24
$-83.9M
$34.9M
Q3 24
$-50.7M
$33.6M
Q2 24
$-37.7M
$40.6M
Q1 24
$-29.6M
$49.1M
毛利率
BKD
BKD
TECH
TECH
Q4 25
24.9%
64.6%
Q3 25
25.9%
Q2 25
26.6%
62.7%
Q1 25
27.4%
67.9%
Q4 24
24.6%
65.3%
Q3 24
25.3%
63.2%
Q2 24
26.3%
66.4%
Q1 24
26.1%
67.4%
营业利润率
BKD
BKD
TECH
TECH
Q4 25
3.0%
18.4%
Q3 25
-6.6%
Q2 25
1.8%
-7.5%
Q1 25
3.6%
12.2%
Q4 24
-0.3%
16.0%
Q3 24
1.3%
13.8%
Q2 24
2.5%
15.0%
Q1 24
2.5%
22.1%
净利率
BKD
BKD
TECH
TECH
Q4 25
-5.3%
12.8%
Q3 25
-14.1%
Q2 25
-5.3%
-5.6%
Q1 25
-8.0%
7.1%
Q4 24
-10.7%
11.7%
Q3 24
-6.5%
11.6%
Q2 24
-4.9%
13.3%
Q1 24
-3.8%
16.2%
每股收益(稀释后)
BKD
BKD
TECH
TECH
Q4 25
$-0.18
$0.24
Q3 25
$-0.48
Q2 25
$-0.18
$-0.11
Q1 25
$-0.28
$0.14
Q4 24
$-0.37
$0.22
Q3 24
$-0.22
$0.21
Q2 24
$-0.17
$0.26
Q1 24
$-0.13
$0.31

资产负债表与财务实力

最新季度各公司的流动性、杠杆与账面价值一览

指标
BKD
BKD
TECH
TECH
现金及短期投资手头流动性
$279.1M
$172.9M
总债务越低越好
$4.3B
$260.0M
股东权益账面价值
$-44.8M
$2.0B
总资产
$6.0B
$2.5B
负债/权益比越低杠杆越低
0.13×

8季度趋势,按日历期对齐

现金及短期投资
BKD
BKD
TECH
TECH
Q4 25
$279.1M
$172.9M
Q3 25
$253.4M
Q2 25
$251.9M
$162.2M
Q1 25
$239.7M
$140.7M
Q4 24
$328.8M
$177.5M
Q3 24
$284.4M
$187.5M
Q2 24
$309.7M
$152.9M
Q1 24
$318.5M
$145.3M
总债务
BKD
BKD
TECH
TECH
Q4 25
$4.3B
$260.0M
Q3 25
$4.3B
Q2 25
$4.3B
$346.0M
Q1 25
$4.3B
$330.0M
Q4 24
$4.1B
$300.0M
Q3 24
$3.7B
$300.0M
Q2 24
$3.7B
$319.0M
Q1 24
$3.8B
$389.0M
股东权益
BKD
BKD
TECH
TECH
Q4 25
$-44.8M
$2.0B
Q3 25
$-6.7M
Q2 25
$105.4M
$1.9B
Q1 25
$146.7M
$2.0B
Q4 24
$212.5M
$2.1B
Q3 24
$292.9M
$2.1B
Q2 24
$340.2M
$2.1B
Q1 24
$374.0M
$2.0B
总资产
BKD
BKD
TECH
TECH
Q4 25
$6.0B
$2.5B
Q3 25
$6.0B
Q2 25
$6.1B
$2.6B
Q1 25
$6.2B
$2.6B
Q4 24
$6.3B
$2.7B
Q3 24
$5.9B
$2.7B
Q2 24
$5.5B
$2.7B
Q1 24
$5.5B
$2.7B
负债/权益比
BKD
BKD
TECH
TECH
Q4 25
0.13×
Q3 25
Q2 25
40.72×
0.18×
Q1 25
29.39×
0.16×
Q4 24
19.12×
0.14×
Q3 24
12.65×
0.14×
Q2 24
10.99×
0.15×
Q1 24
10.05×
0.19×

现金流与资本效率

扣除再投资后实际产生的现金。现金流比净利润更难造假

指标
BKD
BKD
TECH
TECH
经营现金流最新季度
$34.5M
自由现金流经营现金流 - 资本支出
$-29.1M
自由现金流率自由现金流/营收
-3.9%
资本支出强度资本支出/营收
8.4%
现金转化率经营现金流/净利润
过去12个月自由现金流最近4个季度
$16.5M

8季度趋势,按日历期对齐

经营现金流
BKD
BKD
TECH
TECH
Q4 25
$34.5M
Q3 25
$76.5M
Q2 25
$83.6M
$98.2M
Q1 25
$23.4M
$41.1M
Q4 24
$45.2M
$84.3M
Q3 24
$66.5M
$63.9M
Q2 24
$55.7M
$75.5M
Q1 24
$-1.1M
$81.0M
自由现金流
BKD
BKD
TECH
TECH
Q4 25
$-29.1M
Q3 25
$34.9M
Q2 25
$29.1M
$93.3M
Q1 25
$-18.4M
$31.0M
Q4 24
$-5.1M
$77.5M
Q3 24
$11.5M
$54.7M
Q2 24
$4.1M
$57.5M
Q1 24
$-45.5M
$64.5M
自由现金流率
BKD
BKD
TECH
TECH
Q4 25
-3.9%
Q3 25
4.3%
Q2 25
3.6%
29.4%
Q1 25
-2.3%
9.8%
Q4 24
-0.7%
26.1%
Q3 24
1.5%
18.9%
Q2 24
0.5%
18.8%
Q1 24
-5.8%
21.3%
资本支出强度
BKD
BKD
TECH
TECH
Q4 25
8.4%
Q3 25
5.1%
Q2 25
6.7%
1.5%
Q1 25
5.1%
3.2%
Q4 24
6.4%
2.3%
Q3 24
7.0%
3.2%
Q2 24
6.6%
5.9%
Q1 24
5.7%
5.4%
现金转化率
BKD
BKD
TECH
TECH
Q4 25
Q3 25
Q2 25
Q1 25
1.82×
Q4 24
2.42×
Q3 24
1.90×
Q2 24
1.86×
Q1 24
1.65×

财务流量对比

营收 → 毛利润 → 营业利润 → 净利润流向图

业务分部营收拆解

BKD
BKD

Assisted Living And Memory Care$506.7M67%
Independent Living$121.6M16%
Ccrcs Rental$86.3M11%
Reimbursement Costs Managed Communities$36.7M5%
Management Service$2.9M0%

TECH
TECH

Diagnostics And Spatial Biology$81.2M27%
EMEA Excluding UK$75.4M25%
Other$42.4M14%
Instruments$29.6M10%
APAC Excluding Greater China$22.7M8%
Services$22.3M8%
GB$13.7M5%
Royalty$8.5M3%

相关对比